NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 350 filers reported holding NATERA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,193,378 | -19.6% | 26,969 | -11.5% | 0.07% | -17.5% |
| Q2 2023 | $1,483,497 | +17.0% | 30,487 | +33.5% | 0.08% | +2.6% |
| Q1 2023 | $1,268,188 | +159.6% | 22,842 | +87.8% | 0.08% | +143.8% |
| Q4 2022 | $488,588 | +5.5% | 12,163 | +15.1% | 0.03% | -3.0% |
| Q3 2022 | $463,000 | +27.5% | 10,571 | +3.3% | 0.03% | +43.5% |
| Q2 2022 | $363,000 | -18.6% | 10,234 | -6.6% | 0.02% | +21.1% |
| Q1 2022 | $446,000 | -60.5% | 10,956 | -9.4% | 0.02% | -48.6% |
| Q4 2021 | $1,130,000 | -28.3% | 12,098 | -14.5% | 0.04% | -30.2% |
| Q3 2021 | $1,576,000 | +570.6% | 14,143 | +511.5% | 0.05% | +488.9% |
| Q1 2021 | $235,000 | – | 2,313 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |